Karen Hosking
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Predicting resistance to chemotherapy using chromosomal instability signatures.
Journal: Nature genetics
Published: July 21, 2023
Molecular landscape and functional characterization of centrosome amplification in ovarian cancer.
Journal: Nature communications
Published: February 16, 2023
Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models.
Journal: EMBO molecular medicine
Published: January 18, 2022
Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer.
Journal: Nature communications
Published: December 17, 2021
Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer.
Journal: Journal of medical genetics
Published: November 26, 2019
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Journal: Nature genetics
Published: June 04, 2016
Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer: Results of a Retrospective, Single-Institution Study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: May 12, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026